ArticleBoneKEy reports2016

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial.

Huifang Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.